Related Experiment Video
Updated: Mar 16, 2026

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Voice in Friedreich Ataxia
Adam P Vogel1, Mayumi I Wardrop2, Joanne E Folker3
1Centre for Neuroscience of Speech, The University of Melbourne, Melbourne, Australia; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Germany.
Friedreich Ataxia (FRDA) causes mild dysphonia, impacting voice quality and pitch. Speech therapy targeting phonatory stability and speaking rate may improve symptoms and listener perception in FRDA patients.
Area of Science:
- Neurology
- Speech-Language Pathology
- Genetics
Background:
- Friedreich Ataxia (FRDA) is the most prevalent hereditary ataxia.
- Dysarthria is a primary clinical manifestation of FRDA.
Purpose of the Study:
- Characterize the voice profile in individuals with FRDA.
- Inform the development of outcome markers for FRDA.
- Guide speech therapy goals for FRDA patients.
Main Methods:
- Acoustic and perceptual voice analyses were performed on 36 FRDA patients and 30 controls.
- Sustained vowel and connected speech samples were collected.
- Correlations between dysphonia and clinical/genetic factors were examined.
Main Results:
- FRDA patients exhibited mild dysphonia, including hoarseness, increased strain, and altered pitch variability.
- Acoustic analysis revealed higher Cepstral Spectral Index of Dysphonia scores in FRDA patients during vowel production.
- Combined perceptual and acoustic measures achieved over 80% accuracy in differentiating FRDA from control participants.
Conclusions:
- Dysphonia severity in FRDA did not significantly correlate with overall disease severity.
- Speaking rate and syllabic duration correlated with disease onset and duration, affecting listener perception.
- Therapeutic interventions aimed at improving phonatory stability and speaking rate are promising for FRDA management.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Animal Mitochondrial Genetics
Satellite Stem Cells and Muscular Dystrophy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

